Nasdaq - Delayed Quote
USD
Victory RS Science and Technology A (RSIFX)
35.69
-1.38
(-3.72%)
At close: November 2 at 8:10:24 AM EST
Performance Overview
| Morningstar Return Rating | -- |
| YTD Return | 14.39% |
|---|---|
| 5y Average Return | 4.62% |
| Number of Years Up | 22 |
| Number of Years Down | 8 |
| Best 1Y Total Return (Oct 30, 2026) | 65.03% |
| Worst 1Y Total Return (Oct 30, 2026) | -- |
| Best 3Y Total Return | 65.03% |
| Worst 3Y Total Return | -12.08% |
Trailing Returns (%) Vs. Benchmarks
Monthly Total Returns
RSIFX
Category
- YTD
- 25.13%
- 12.31%
- 1-Month
- 2.71%
- 6.23%
- 3-Month
- 1.99%
- 8.63%
- 1-Year
- 27.59%
- 53.90%
- 3-Year
- 31.54%
- 27.50%
- 5-Year
- 7.37%
- 28.80%
- 10-Year
- 15.90%
- 18.74%
- Last Bull Market
- 25.95%
- 24.03%
- Last Bear Market
- -26.09%
- -20.41%
Annual Total Return (%) History
Year
RSIFX
Category
Past Quarterly Returns
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
|
2026
|
-10.35% | 36.86% | 1.99% | -- |
|
2025
|
-14.91% | 23.56% | 10.75% | 1.97% |
|
2024
|
12.31% | 1.72% | 6.79% | 8.95% |
|
2023
|
11.14% | 11.50% | -7.19% | 15.27% |
|
2022
|
-21.28% | -26.09% | -4.12% | 1.26% |
|
2021
|
-1.40% | 4.97% | -9.12% | -3.52% |
|
2020
|
-16.90% | 42.53% | 6.97% | 30.25% |
|
2019
|
25.41% | 3.26% | -7.83% | 16.72% |
|
2018
|
6.17% | 11.10% | 7.27% | -21.54% |
|
2017
|
14.75% | 6.78% | 12.32% | 5.17% |
Rank in Category (By Total Return)
| YTD | 62 |
| 1-Month | 64 |
|---|---|
| 3-Month | 35 |
| 1-Year | 57 |
| 3-Year | 54 |
| 5-Year | 76 |
Load Adjusted Returns
| 1-Year | 20.25% |
| 3-Year | 28.97% |
|---|---|
| 5-Year | 6.10% |
| 10-Year | 15.22% |
Performance & Risk
| YTD Return | 14.39% |
| 5y Average Return | 4.62% |
| Rank in Category (ytd) | 62 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 1.63 |
| Morningstar Risk Rating |
Fund Overview
| Category | Technology |
| Fund Family | Victory Capital Management Inc. |
| Net Assets | 255.66M |
| YTD Return | 25.13% |
| Yield | 0.00% |
| Morningstar Rating | |
| Inception Date | May 01, 2007 |
Fund Summary
The fund invests, under normal circumstances, at least 80% of its assets in science and/or technology companies. The fund principally invests in equity securities and may invest in companies of any size, which typically includes U.S. companies but may also invest any portion of its assets in foreign securities, including depositary receipts such as American Depositary Receipts (“ADRs”) and Global Depositary Receipts (“GDRs”). The fund typically invests in equity securities of U.S. companies but may also invest any portion of its assets in foreign securities.
